Experts in the field of obstetrics and epidemiology share how they are helping their patients make informed clinical decisions about vaccination for SARS-CoV-2.
Investigators assessed response to vaccination with the Moderna or Pfizer-BioNTech COVID-19 vaccines in pregnant and nonpregnant lactating women.
The extension was based on data from ongoing stability assessment studies.
Clinicians report the cutaneous reactions experienced by healthcare workers who received the Pfizer COVID-19 vaccine.
The report included 10262 SARS-CoV-2 vaccine breakthrough infections in 46 US states and territories among 101 million fully vaccinated individuals as of April 30, 2021.
The TeenCOVE study (ClinicalTrials.gov: NCT04649151) included over 3700 US adolescents aged 12 to less than 18 years.
The safety of the vaccine in this patient population was based on data from 2260 adolescent participants.
Investigators vaccinated exclusively or partially breastfeeding women and examined their breast milk samples to determine levels of antibodies against SARS-CoV-2.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.
The American College of Rheumatology updated COVID-19 vaccine clinical guidance to include recommendations regarding medication timing considerations during the management of patients with rheumatic and musculoskeletal diseases.
